In the first ever case of its kind, on February11 the Patents Court ordered the payment of £1.5 million ($2.1 million) in "employee compensation" to two former employees of GE Healthcare who were inventors of chemical complexes which form the basis of GE Healthcare's blockbuster heart imaging product Myoview. The claim was made under little-used provisions of the Patents Act 1977 which entitle employees named as inventors on patents to seek compensation if the patent has been of "outstanding benefit" to the employer. In this case the Court found that this hurdle had been overcome, assessed the monetary value of the patents to GE Healthcare at £50 million and awarded the inventors a 3% share of that benefit.